![](https://sdbig.com/wp-content/uploads/2024/01/medium-0MAsF1.jpeg)
Sanofi plans to buy assets from U.S. biopharmaceutical company Inhibrx in a deal valued at up to $2.2 billion.
San Diego Black Investors Group
Sanofi plans to buy assets from U.S. biopharmaceutical company Inhibrx in a deal valued at up to $2.2 billion.